SABBY MANAGEMENT, LLC - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 32 filers reported holding CLEVELAND BIOLABS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2014$108,000
-73.3%
377,156
-57.2%
0.00%
-81.2%
Q3 2014$404,000
+174.8%
881,056
+187.8%
0.02%
+166.7%
Q2 2014$147,000
-88.2%
306,165
-83.2%
0.01%
-91.4%
Q1 2014$1,244,0001,826,1580.07%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q2 2014
NameSharesValueWeighting ↓
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 697,300$1,102,0000.26%
GOODNOW INVESTMENT GROUP, LLC 601,889$951,0000.17%
MACROVIEW INVESTMENT MANAGEMENT LLC 38,000$60,0000.06%
BHR Capital LLC 300,000$474,0000.05%
LADENBURG THALMANN FINANCIAL SERVICES INC. 746,200$1,172,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 67,200$106,0000.02%
Van Cleef Asset Management,Inc 20,000$32,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 69,981$111,0000.01%
KINGS POINT CAPITAL MANAGEMENT 10,000$16,0000.01%
TAURUS ASSET MANAGEMENT, LLC 15,000$24,0000.01%
View complete list of CLEVELAND BIOLABS INC shareholders